Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
0 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Eikon Therapeutics, Inc.’s names, not what it holds today.
Patents granted
0
by type: not read, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
7
6 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
EIKON THERAPEUTICS, INC. its own name
US, as the owner printed on each patent
6 publishedEIKON THERAPEUTICS, INC. its own name
named as the applicant on its applications, in US
1 published
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 9, 2025 | 2025/0314869 | SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS | Measurement | EIKON THERAPEUTICS, INC. |
| Oct 9, 2025 | 2025/0314641 | OBLIQUE LINE SCANNER SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS | Computer technology | EIKON THERAPEUTICS, INC. |
| Oct 9, 2025 | 2025/0314640 | SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS | Analysis of biological materials | EIKON THERAPEUTICS, INC. |
| Oct 9, 2025 | 2025/0314639 | SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS | Analysis of biological materials | EIKON THERAPEUTICS, INC. |
| Oct 9, 2025 | 2025/0314638 | OBLIQUE LINE SCANNER SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS | Analysis of biological materials | EIKON THERAPEUTICS, INC. |
| Oct 9, 2025 | 2025/0314586 | SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS | Analysis of biological materials | EIKON THERAPEUTICS, INC. |
| Mar 23, 2023 | 2023/0086732 | PHOTOACTIVE FLUORESCENT COMPOUNDS AND USE THEREOF FOR LABELING OF PROTEINS | Organic fine chemistry | EIKON THERAPEUTICS, INC. |
What it applied for, 2024 to 2025: Analysis of biological materials 4 · Measurement 1 · Computer technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.